PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.35%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.23%
Negative EBIT growth while QRVO is at 810.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.23%
Negative operating income growth while QRVO is at 6.61%. Joel Greenblatt would press for urgent turnaround measures.
-22.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.74%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-23.91%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.77%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
1.80%
Dividend growth of 1.80% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-34.44%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
49.18%
10Y revenue/share CAGR at 50-75% of QRVO's 95.48%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
130.13%
5Y revenue/share CAGR above 1.5x QRVO's 27.97%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.62%
Positive 3Y CAGR while QRVO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
101.41%
10Y OCF/share CAGR in line with QRVO's 108.03%. Walter Schloss would see both as similarly efficient over the decade.
146.61%
5Y OCF/share CAGR above 1.5x QRVO's 5.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
69.41%
Positive 3Y OCF/share CAGR while QRVO is negative. John Neff might see a big short-term edge in operational efficiency.
323.19%
Below 50% of QRVO's 1921.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1889.18%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
68.97%
Positive short-term CAGR while QRVO is negative. John Neff would see a clear advantage in near-term profit trajectory.
181.93%
Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
25.48%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.20%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
91.76%
Dividend/share CAGR of 91.76% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
106.54%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
88.39%
3Y dividend/share CAGR of 88.39% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.95%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.29%
Negative asset growth while QRVO invests at 1.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.11%
Under 50% of QRVO's 3.14%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.93%
We cut SG&A while QRVO invests at 19.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.